Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-040988
Filing Date
2021-06-16
Accepted
2021-06-16 17:17:58
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4024
  Complete submission text file 0001209191-21-040988.txt   5431
Mailing Address C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Behanna Heather (Reporting) CIK: 0001751873 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40288 | Film No.: 211022355

Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations